Gilgamesh Pharmaceuticals
About:
Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.
Website: https://www.gilgameshpharmaceutical.com
Twitter/X: gilgameshrx
Top Investors: Alumni Ventures, Y Combinator, Bossanova Investimentos, Gaingels, Pioneer Fund
Description:
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health worldwide has reached epidemic proportions and novel treatments have not kept pace with the urgent need to treat depression, anxiety, drug addiction and many other devastating diseases. Our purpose is to accelerate treatments and fundamentally improve mental health.
$82.6M
Less than $1M
New York, New York, United States
2019-01-01
Investors(AT)GilgameshPharmaceutical.com
Andrew Kruegel, Dalibor Sames, Jeff Witkin, Jonathan Sporn, Mike Cunningham
11-50
2024-03-14
Private
© 2025 bioDAO.ai